Partner with us
Why Sathgen
Join our journey as we discover novel and effective treatments for hard to cure cancers.
Lead Compound
Demonstrated in vitro and in vivo efficacy against triple-negative breast cancer and prostate cancer.
Strong Backing
Supported by Godavari Biorefineries Limited and strategic partnership with CROs for early and global clinical development expertise.
Robust Pipeline
Over 40 preclinical compounds targeting a diverse range of cancers. One compound in Phase 1
Impactful Investment
Opportunity to contribute to significant advancements in cancer treatment with potential for financial returns.